Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
2 days ago
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.

Lorecivivint for knee OA unsuccessful in phase IIa trial

05 Oct 2020

The novel Wnt pathway modulator lorecivivint does not appear to be effective for treating pain and inhibiting structural progression in moderate-to-severe knee osteoarthritis (OA), according to the results of a phase IIa trial.

In total, 452 patients aged 40–80 years with Kellgren/Lawrence (K/L) radiographic disease stage 2 or stage 3 OA were randomized to receive a single 2‐ml intra-articular injection of lorecivivint at 0.03 mg (n=112), 0.07 mg (n=117), or 0.23 mg (n=109) or placebo (n=114).

Of the patients who completed the study, 103 (92 percent) were on lorecivivint 0.03 mg, 107 (91.5 percent) on 0.07 mg, 95 (86.4 percent) on 0.23 mg, and 97 (83.6 percent) were on placebo. Their mean age was 60.3 years and mean body mass index 29.9 kg/m2, while 58.9 percent of the population were women.

At week 13, all groups demonstrated clinically meaningful (≥20‐point) improvements from baseline in the primary endpoint of Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score. The study drug did not produce significant improvements compared with placebo (mean change, −23.3 on 0.03 mg, −23.5 on 0.07 mg, −21.3 on 0.23 mg vs −22.1 on placebo; p>0.05 for all comparisons).

However, at week 52, lorecivivint 0.07 mg showed superiority over placebo in terms of WOMAC pain and function scores in the subgroups of patients with unilateral symptoms of knee OA (difference, −8.73; p=0.049 and difference, −10.26; p=0.036, respectively) and those with unilateral symptoms but without widespread pain (difference, −11.21; p=0.025 and difference, −13.38; p=0.017, respectively)

None of the treatment groups achieved a significant change in medial joint space width (JSW) at week 52 (mean change, −0.04 mm on 0.03 mg, −0.09 mm on 0.07 mg, −0.16 mm on 0.23 mg, and −0.14 mm on placebo).

The 0.07-mg lorecivivint dose likewise significantly improved medial JSW compared with placebo at week 52 among patients with unilateral symptoms of knee OA (difference, 0.39 mm; p=0.021) and those with unilateral symptoms but without widespread pain (difference, 0.42 mm; p=0.032).

Lorecivivint was safe and well tolerated.

The findings point to a target population in whom lorecivivint exerts potential efficacy, the researchers said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
Pearl Toh, 26 Nov 2020
Inhaled corticosteroid (ICS) should be the mainstay of long-term asthma management — such is the key message of the latest Singapore ACE* Clinical Guidance (ACG) for asthma, released in October 2020.
2 days ago
Daily intake of cow’s milk formula in early life helps prevent the development of cow’s milk allergy later on without competing with breastfeeding, a recent study has found.